Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06856525
PHASE2/PHASE3

Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology

Sponsor: Y. Michael Shim, MD

View on ClinicalTrials.gov

Summary

A two-center, longitudinal assessment of 40 electronic cigarette users and 40 healthy controls at the initial visit and a follow-up visit 12 months later. This study will determine the impact of electronic cigarette use on pulmonary gas exchange capacity and then corroborate the Hyperpolarized Xenon MRI (HXeMRI) results with the cardiopulmonary stress test at the initial visit and a follow-up visit 12 months later.

Official title: Dissolved Phase Hyperpolarized Xenon-129 MRI: a Novel Biomarker to Quantify Pulmonary Pathology in Healthy Participants and E-cigarette Users

Key Details

Gender

All

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2024-12-19

Completion Date

2032-12-31

Last Updated

2026-03-17

Healthy Volunteers

Yes

Interventions

DRUG

Hyperpolarized xenon 129

Determine the impact of e-cigarette use on pulmonary gas exchange capacity in interstitial tissues and capillaries using hyperpolarized xenon-129 MRI.

DIAGNOSTIC_TEST

Cardiopulmonary Stress Test

Exercise stress test to evaluate cardiac and pulmonary fitness.

DIAGNOSTIC_TEST

Pulmonary Function Test

Standard clinic pulmonary function test to evaluate lung function

DIAGNOSTIC_TEST

Chest CT

Clinical standard chest computer tomography to evaluate any lung tissue scars or air movement.

Locations (2)

Duke University

Durham, North Carolina, United States

University of Virginia

Charlottesville, Virginia, United States